March 4, 2018 – By Adrian Erickson

Investors sentiment increased to 1.25 in Q3 2017. Its up 0.05, from 1.2 in 2017Q2. It is positive, as 20 investors sold INSYS Therapeutics, Inc. shares while 20 reduced holdings. 19 funds opened positions while 31 raised stakes. 18.21 million shares or 3.74% more from 17.56 million shares in 2017Q2 were reported.
Orbimed Advsrs Ltd Company has invested 0.52% in INSYS Therapeutics, Inc. (NASDAQ:INSY). Invesco holds 703,962 shares. Oz Mngmt L P holds 0% or 88,800 shares in its portfolio. Qs Investors Ltd Liability reported 0.01% in INSYS Therapeutics, Inc. (NASDAQ:INSY). Panagora Asset reported 108,416 shares or 0% of all its holdings. Morgan Stanley has invested 0% of its portfolio in INSYS Therapeutics, Inc. (NASDAQ:INSY). 29,102 were accumulated by Royal Savings Bank Of Canada. Massachusetts-based Fmr Limited Liability Com has invested 0% in INSYS Therapeutics, Inc. (NASDAQ:INSY). Manufacturers Life Company The invested in 0% or 24,726 shares. Mirae Asset Glob Invs Limited holds 0.17% of its portfolio in INSYS Therapeutics, Inc. (NASDAQ:INSY) for 1.03M shares. National Bank & Trust Of Montreal Can has 0% invested in INSYS Therapeutics, Inc. (NASDAQ:INSY). D E Shaw And Co owns 134,714 shares. Tower Rech Capital Lc (Trc) stated it has 0% of its portfolio in INSYS Therapeutics, Inc. (NASDAQ:INSY). Weiss Multi has invested 0.01% in INSYS Therapeutics, Inc. (NASDAQ:INSY). 33,211 were accumulated by Credit Suisse Ag.

The stock of Insys Therapeutics Inc (NASDAQ:INSY) registered an increase of 7.19% in short interest. INSY’s total short interest was 12.51M shares in March as published by FINRA. Its up 7.19% from 11.68M shares, reported previously. With 1.58 million shares average volume, it will take short sellers 8 days to cover their INSY’s short positions. The short interest to Insys Therapeutics Inc’s float is 66.73%.

The stock increased 6.29% or $0.46

Read More Here...